Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease.

Malkasian GD Jr, Knapp RC, Lavin PT, Zurawski VR Jr, Podratz KC, Stanhope CR, Mortel R, Berek JS, Bast RC Jr, Ritts RE.

Am J Obstet Gynecol. 1988 Aug;159(2):341-6.

PMID:
2457318
2.

Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.

Einhorn N, Bast RC Jr, Knapp RC, Tjernberg B, Zurawski VR Jr.

Obstet Gynecol. 1986 Mar;67(3):414-6.

PMID:
2418395
3.

Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses.

O'Connell GJ, Ryan E, Murphy KJ, Prefontaine M.

Obstet Gynecol. 1987 Dec;70(6):930-2.

PMID:
3479735
4.

Comparison of serum CA 125, clinical impression, and ultrasound in the preoperative evaluation of ovarian masses.

Finkler NJ, Benacerraf B, Lavin PT, Wojciechowski C, Knapp RC.

Obstet Gynecol. 1988 Oct;72(4):659-64.

PMID:
3047614
5.
6.

Preoperative serum tumor-associated antigen levels in women with pelvic masses.

Soper JT, Hunter VJ, Daly L, Tanner M, Creasman WT, Bast RC Jr.

Obstet Gynecol. 1990 Feb;75(2):249-54.

PMID:
2300353
7.

Serum CA 125 levels in preoperative evaluation of pelvic masses.

Vasilev SA, Schlaerth JB, Campeau J, Morrow CP.

Obstet Gynecol. 1988 May;71(5):751-6.

PMID:
3162763
8.

Prospective multicenter study on CA 125 in postmenopausal pelvic masses.

Maggino T, Gadducci A, D'Addario V, Pecorelli S, Lissoni A, Stella M, Romagnolo C, Federghini M, Zucca S, Trio D, et al.

Gynecol Oncol. 1994 Aug;54(2):117-23.

PMID:
8063233
9.

Evaluation of CA 125 levels in differentiating malignant from benign tumors in patients with pelvic masses.

Chen DX, Schwartz PE, Li XG, Yang Z.

Obstet Gynecol. 1988 Jul;72(1):23-7.

PMID:
3164105
10.

CA 125 in the diagnosis of pelvic masses.

Mogensen O, Mogensen B, Jakobsen A.

Eur J Cancer Clin Oncol. 1989 Aug;25(8):1187-90.

PMID:
2767108
11.

Serum CA 125 levels in a group of nonhospitalized women: relevance for the early detection of ovarian cancer.

Zurawski VR Jr, Broderick SF, Pickens P, Knapp RC, Bast RC Jr.

Obstet Gynecol. 1987 Apr;69(4):606-11.

PMID:
2434895
12.

CA 125 in preoperative evaluation of pelvic masses.

Pyrgiotis E, Salamalekis E, Loghis C, Dima C, Zourlas PA.

Eur J Gynaecol Oncol. 1993;14(4):279-82.

PMID:
8344320
13.

Clinical utility of CA 125 in preoperative diagnosis of patients with pelvic masses.

Finkler NJ.

Eur J Obstet Gynecol Reprod Biol. 1993 Apr;49(1-2):105-7.

PMID:
8365503
14.

[Experiences with CA 125, a tumor marker for malignant epithelial ovarian tumors].

Crombach G, Zippel HH, Würz H.

Geburtshilfe Frauenheilkd. 1985 Apr;45(4):205-12. German.

PMID:
2408962
15.

Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses.

Patsner B, Mann WJ, Chalas E.

Obstet Gynecol. 1988 Jun;71(6 Pt 1):949-50. No abstract available.

PMID:
3163416
16.

Estimation of probability of malignancy using a logistic model combining physical examination, ultrasound, serum CA 125, and serum CA 72-4 in postmenopausal women with a pelvic mass: an international multicenter study.

Schutter EM, Sohn C, Kristen P, Möbus V, Crombach G, Kaufmann M, Caffier H, Kreienberg R, Verstraeten AA, Kenemans P.

Gynecol Oncol. 1998 Apr;69(1):56-63.

PMID:
9570999
17.

Preoperative evaluation of D-dimer and CA 125 levels in differentiating benign from malignant ovarian masses.

Gadducci A, Baicchi U, Marrai R, Ferdeghini M, Bianchi R, Facchini V.

Gynecol Oncol. 1996 Feb;60(2):197-202.

PMID:
8631538
18.

Preoperative serum vascular endothelial growth factor (VEGF) in ovarian masses.

Tanir HM, Ozalp S, Yalcin OT, Colak O, Akcay A, Senses T.

Eur J Gynaecol Oncol. 2003;24(3-4):271-4.

PMID:
12807238
19.

The clinical significance of pre-operative serum CA 125 in ovarian cancer.

Cruickshank DJ, Fullerton WT, Klopper A.

Br J Obstet Gynaecol. 1987 Jul;94(7):692-5.

PMID:
2441738
20.

CA 125 in the follow-up of patients with ovarian cancer.

Koelbl H, Schieder K, Neunteufel W, Bieglmayer C.

Eur J Obstet Gynecol Reprod Biol. 1988 Apr;27(4):335-42.

PMID:
3164284

Supplemental Content

Support Center